NCT06974110 2026-04-15
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
MOMA Therapeutics
Phase 1 Recruiting
MOMA Therapeutics
Nanfang Hospital, Southern Medical University
Mayo Clinic
Tongji Hospital
Ohio State University Comprehensive Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Shandong Cancer Hospital and Institute
H. Lee Moffitt Cancer Center and Research Institute
Boston Scientific Corporation